Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin in knee osteoarthritis
NCT04770064Phase 2Withdrawn
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in knee osteoarthritis (OA). Planned start Jun 2023; status: withdrawn.
02
Drugs
fisetin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04770064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04770064.